AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
SITAGLIPTIN in Zimbabwe
14 products registered with MCAZ — 14 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| SITAMAC 100 TABLET, COATED; ORAL | 2026/17.7/7462 | MACLEODS PHARMACEUTICALS LIMITED | active | 10 Jun 2031 |
| GLINSIP 100 TABLET, COATED; ORAL | 2023/17.7/6437 | HETERO LABS LTD | active | 30 Jun 2028 |
| GLINSIP 50 TABLET, COATED; ORAL | 2023/17.7/6436 | HETERO LABS LTD | active | 30 Jun 2028 |
| REMEVIA-50 TABLET, COATED; ORAL | 2024/17.7/6769 | REMEDICA LTD | active | 31 Dec 2027 |
| SITAZUCA 25 TABLET, COATED; ORAL | 2024/17.7/6694 | MYLAN LABORATORIES LIMITED [OTL] | active | 31 Dec 2027 |
| REMEVIA 25MG TABLET, COATED; ORAL | 2025/17.7/7094 | REMEDICA LTD | active | 31 Dec 2027 |
| JANUVIA TABLET, COATED; ORAL | 2014/17.7/4940 | MSD PTY LTD | active | 31 Dec 2027 |
| NONE TABLET, COATED; ORAL | 2025/17.7/7266 | COSPHARM INVESTMENTS PVT LTD | active | 31 Dec 2027 |
| REMEVIA-100 TABLET, COATED; ORAL | 2024/17.7/6770 | REMEDICA LTD | active | 31 Dec 2027 |
| SITABET 50 TABLET, COATED; ORAL | 2025/17.7/7059 | N2SA LIMITED | active | 31 Dec 2027 |
| SITAGLIPTIN TABLET, COATED; ORAL | 2024/17.7/6695 | MYLAN LABORATORIES LIMITED | active | 31 Dec 2027 |
| SITABET 100 TABLET, COATED; ORAL | 2025/17.7/7060 | N2SA LIMITED | active | 31 Dec 2027 |
| SITAZUCA 100 TABLET, COATED; ORAL | 2024/17.7/6696 | MYLAN LABORATORIES LIMITED [OTL] | active | 31 Dec 2027 |
| JANUVIA TABLET, COATED; ORAL | 2014/17.7/4939 | MSD PTY LTD | active | 31 Dec 2027 |
SITAGLIPTIN — MCAZ Registration Details
MCAZ (Zimbabwe) has 14 registered products containing SITAGLIPTIN, of which 14 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track SITAGLIPTIN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.